| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |